Dr. Jodi M Gilman, PhD
Claim this profileMassachusetts General Hospital
Studies Substance Abuse
Studies Chronic Persistent Surgical Pain
3 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Jodi M Gilman, PhD is currently running
Suvorexant
for Cannabis Use Disorder
The goal of this study is to observe the impact of suvorexant, sold as BELSOMRA, on brain activity of people who frequently use cannabis. Suvorexant is an FDA-approved medication to treat insomnia. Researchers think that suvorexant may reduce activity in certain parts of the brain associated with cannabis use. Researchers are studying if this medication does affect brain activity in these areas. For this study, participants will be asked to complete four study visits over approximately 14 days. Each study visit will include interviews, questionnaires, and collection of biological samples for laboratory testing. All participants will be asked to take suvorexant, an FDA approved medication for treatment of insomnia, for 14 days. They will complete two one-hour functional Magnetic Resonance Imaging (fMRI) scans: one before starting the study medication and one after 14 days of taking the study medication. MRI is used in typical medical settings and is considered to be safe. Participants will also be asked to complete a short daily survey for approximately 14 days.
Recruiting3 awards Phase 42 criteria
CBD
for Chronic Low Back Pain
This study will investigate whether cannabidiol (CBD), the primary centrally and peripherally active non-intoxicating compound in the cannabis plant, exerts anti-neuroinflammatory effects in patients with chronic low back pain (cLBP) with or without mild-to-moderate depression.
Recruiting0 awards Phase 2
More about Jodi M Gilman, PhD
Clinical Trial Related4 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Jodi M Gilman, PhD has experience with
- Medical Marijuana
- Prescription Opioid Taper Support (POTS)
- Suvorexant
- Cannabidiol
Breakdown of trials Jodi M Gilman, PhD has run
Chronic Persistent Surgical Pain
Opioid Use Disorder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jodi M Gilman, PhD specialize in?
Jodi M Gilman, PhD focuses on Substance Abuse and Chronic Persistent Surgical Pain. In particular, much of their work with Substance Abuse has involved TSPO positive patients, or patients who are undergoing treatment.
Is Jodi M Gilman, PhD currently recruiting for clinical trials?
Yes, Jodi M Gilman, PhD is currently recruiting for 2 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Jodi M Gilman, PhD has studied deeply?
Yes, Jodi M Gilman, PhD has studied treatments such as Medical Marijuana, Prescription Opioid Taper Support (POTS), Suvorexant.
What is the best way to schedule an appointment with Jodi M Gilman, PhD?
Apply for one of the trials that Jodi M Gilman, PhD is conducting.
What is the office address of Jodi M Gilman, PhD?
The office of Jodi M Gilman, PhD is located at: Massachusetts General Hospital, Boston, Massachusetts 02114-2523 United States. This is the address for their practice at the Massachusetts General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.